Regional, sex and age differences in diagnostic testing among participants in NAVIGATE-ESUS trial
International J Stroke
Antonio Arauz, Fabiola Serrano, Lesly A Pearce, Scott E Kasner, Robert G Hart, et al
October 2019
Read More
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial
Eur J Prev Cardiology
Thomas Vanassche, Sonia S Anand, Olga Shestakovska, Salim Yusuf, Stuart J Connolly, John W Eikelboom, Jackie Bosch, et al
October 2019
HOPE-4: A community-based comprehensive intervention to reduce cardiovascular risk in hypertension: A cluster-randomised controlled trial
The Lancet
JD Schwalm, T McCready, P Lopez-Jaramillo, K Yusoff, A Attaran, P Lamelas, PA Camacho, F Majid, SI Bangdiwala, L Thabane, S Islam, M McKee, S Yusuf
October 2019
Dabigatran reversal with idarucizumab in patients with renal impairment
JACC
John W. Eikelboom, Joanne van Ryn, Paul Reilly, Elaine M. Hylek, Amelie Elsaesser, Stephan Glund, Charles V. Pollack and Jeffrey I. Weitz
October 2019
CAHHM Study: Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease
EHJ Cardiovascular Imaging
Sonia S Anand (1st author), Dipika Desai, Koon Teo, Salim Yusuf, Melissa Thomas, Karleen M Schulze, et al
September 2019
Effects of accelerated versus standard care surgery on the risk of acute kidney injury in patients with a hip fracture: a substudy protocol of HIP ATTACK international RCT
BMJ Open
Flavia K Borges, PJ Devereaux, Meaghan Cuerden, Mohit Bhandari, Ernesto Guerra-Farfán et al
September 2019
Association between low-dose rivaroxaban with or without aspirin and ischemic stroke subtypes – a secondary analysis of the COMPASS trial
JAMA Neurology
KS Perera, KKH Ng, S Nayar, L Catanese, L Dyal, M Sharma, SJ Connolly, S Yusuf, J Bosch, JW Eikelboom, RG Hart
September 2019
Safety of continuing trastuzumab despite mild cardiotoxicity: SCHOLAR trial
JACC CardioOnc
DP Leong, T Cosman, MM Alhussein, NK Tyagi, S Karampatos, CC Barron, D Wright, V Tandon, P Magloire, P Joseph, D Conen, PJ Devereaux, PM Ellis, SD Mukherjee, S Dhesy-Thind
September 2019
Complete revascularization with multivessel PCI for myocardial infarction: COMPLETE trial
New England Journal of Medicine
SR Mehta, DA Wood, RF Storey, R Mehran, KR Bainey, H Nguyen, B Meeks, G Di Pasquale, J Lopez-Sendon, DP Faxon, L Mauri, SV Rao et al
September 2019
Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after noncardiac surgery: POISE-1
Eur Heart J
David Conen, Pablo Alonso-Coello, James Douketis, Maria Tiboni, Gordon Guyatt, Kumar Balasubramanian, Salim Yusuf, P J Devereaux et al.
June 2019
PURE: Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents
Lancet
M Dehghan, A Mente, S Rangarajan, P Sheridan, V Mohan, R Iqbal, R Gupta, S Lear, E Wentzel-Viljoen, A Avezum, P Lopez-Jaramillo, P Mony, RP Varma, R Kumar, J Chifamba, KF Alhabib, N Mohammadifard, A Oguz, F Lanas, D Rozanska, KB Bostrom, K Yusoff, LP Tsolkile, A Dans, AH Yusufali, A Orlandini, P Poirier, R Khatib, B Hu, Li Wei, L Yin, A Deeraili, K Yeates, R Yusuf, N Ismail, D Mozaffarian, K Teo, SS Anand, S Yusuf
November 2018
PURE: Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
Lancet Diabetes Endocrinology
CK Chow, C Ramasundarahettige, W Hu, KF AlHabib, A Avezum, X Cheng, J Chifamba, G Dagenais, A Dans, BA Egbujie, R Gupta, R Iqbal, N Ismail, MV Keskinler, R Khatib, L Kruger, R Kumar, F Lanas, S Lear, P Lopez-Jaramillo, M McKee, N Mohammadifard, V Mohan, P Mony, A Orlandini, A Rosengren, K Vijayakumar, L Wei, K Yeates, K Yusoff, R Yusuf, A Yusufali, K Zatonska, Y Zhou, S Islam, D Corsi, S Rangarajan, K Teo, HC Gerstein, S Yusf
October 2018
PURE: Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study
Lancet
A Mente, M O'Donnell, S Rangarajan, M McQueen, G Dagenais, A Wielgosz, S Lear, ST Lap Ah, L Wei, R Diaz, A Avezum, P Lopez-Jaramillo, F Lanas, P Mony, A Szuba, R Iqbal, R Yusuf, N Mohammadifard, R Khatib, K Yusoff, N Ismail, S Gulec, A Rosengren, A Yusufali, L Kruger, LP Tsolekile, J Chifamba, A Dans, KF Alhabib, K Yeates, K Teo, S Yusuf
August 2018
PURE: Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world
BMJ Heart
P Joseph, S Yusuf, SF Lee, Q Ibrahim, K Teo, S Rangarajan, R Gupta, A Rosengren, SA Lear, A Avezum, P Lopez-Jaramillo, S Gulec, A Yusufali, J Chifamba, F Lanas, R Kumar, N Mohammadifard, V Mohan, P Mony, A Kruger, X Liu, B Guo, W Zhao, Y Yang, R Pillai, R Diaz, A Krishnapillai, R Iqbal, R Yusuf, A Szuba, SS Anand
April 2018
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
Lancet Global Health
A Murphy, B Palafox, O O'Donnell, D Stuckler, P Perel, KF AlHabib, A Avezum, X Bai, J Chifamba, CK Chow, DJ Corsi, GR Dagenais, AL Dans, R Diaz, AN Erbakan, N Ismail, R Iqbal, R Kelishadi, R Khatib, F Lanas, SA Lear, W Li, J Lu, P Lopez-Jaramillo, V Mohan, N Monself, PK Mony, T Puoane, S Rangarajan, A Rosengren, AE Schutte, M Sintaha, KK Teo, A Weilgosz, K Yeates, L Yin, K Yusoff, K Zatonska, S Yusuf, M McKee
March 2018
